294 related articles for article (PubMed ID: 28598356)
1. NF-κB Signalling in Glioblastoma.
Soubannier V; Stifani S
Biomedicines; 2017 Jun; 5(2):. PubMed ID: 28598356
[TBL] [Abstract][Full Text] [Related]
2. Natural Small Molecules Targeting NF-κB Signaling in Glioblastoma.
Uddin MS; Kabir MT; Mamun AA; Sarwar MS; Nasrin F; Emran TB; Alanazi IS; Rauf A; Albadrani GM; Sayed AA; Mousa SA; Abdel-Daim MM
Front Pharmacol; 2021; 12():703761. PubMed ID: 34512336
[TBL] [Abstract][Full Text] [Related]
3. Aberrant constitutive activation of nuclear factor kappaB in glioblastoma multiforme drives invasive phenotype.
Raychaudhuri B; Han Y; Lu T; Vogelbaum MA
J Neurooncol; 2007 Oct; 85(1):39-47. PubMed ID: 17479228
[TBL] [Abstract][Full Text] [Related]
4. NF-kappaB-independent sensitization of glioblastoma cells for TRAIL-induced apoptosis by proteasome inhibition.
La Ferla-Brühl K; Westhoff MA; Karl S; Kasperczyk H; Zwacka RM; Debatin KM; Fulda S
Oncogene; 2007 Jan; 26(4):571-82. PubMed ID: 16909119
[TBL] [Abstract][Full Text] [Related]
5. The landscape of the mesenchymal signature in brain tumours.
Behnan J; Finocchiaro G; Hanna G
Brain; 2019 Apr; 142(4):847-866. PubMed ID: 30946477
[TBL] [Abstract][Full Text] [Related]
6. DNA damage-induced NF-κB activation in human glioblastoma cells promotes miR-181b expression and cell proliferation.
Xu RX; Liu RY; Wu CM; Zhao YS; Li Y; Yao YQ; Xu YH
Cell Physiol Biochem; 2015; 35(3):913-25. PubMed ID: 25633526
[TBL] [Abstract][Full Text] [Related]
7. Nuclear factor-κB in glioblastoma: insights into regulators and targeted therapy.
Cahill KE; Morshed RA; Yamini B
Neuro Oncol; 2016 Mar; 18(3):329-39. PubMed ID: 26534766
[TBL] [Abstract][Full Text] [Related]
8. NF-kappaB inhibition improves the sensitivity of human glioblastoma cells to 5-aminolevulinic acid-based photodynamic therapy.
Coupienne I; Bontems S; Dewaele M; Rubio N; Habraken Y; Fulda S; Agostinis P; Piette J
Biochem Pharmacol; 2011 Mar; 81(5):606-16. PubMed ID: 21182827
[TBL] [Abstract][Full Text] [Related]
9. Silencing NUDT21 Attenuates the Mesenchymal Identity of Glioblastoma Cells via the NF-κB Pathway.
Lou JC; Lan YL; Gao JX; Ma BB; Yang T; Yuan ZB; Zhang HQ; Zhu TZ; Pan N; Leng S; Song GJ; Zhang B
Front Mol Neurosci; 2017; 10():420. PubMed ID: 29311812
[TBL] [Abstract][Full Text] [Related]
10. NF-κB, Mesenchymal Differentiation and Glioblastoma.
Yamini B
Cells; 2018 Aug; 7(9):. PubMed ID: 30200302
[TBL] [Abstract][Full Text] [Related]
11. Targeting NF-κB in glioblastoma: A therapeutic approach.
Friedmann-Morvinski D; Narasimamurthy R; Xia Y; Myskiw C; Soda Y; Verma IM
Sci Adv; 2016 Jan; 2(1):e1501292. PubMed ID: 26824076
[TBL] [Abstract][Full Text] [Related]
12. Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-κB-dependent Manner.
Kim SH; Ezhilarasan R; Phillips E; Gallego-Perez D; Sparks A; Taylor D; Ladner K; Furuta T; Sabit H; Chhipa R; Cho JH; Mohyeldin A; Beck S; Kurozumi K; Kuroiwa T; Iwata R; Asai A; Kim J; Sulman EP; Cheng SY; Lee LJ; Nakada M; Guttridge D; DasGupta B; Goidts V; Bhat KP; Nakano I
Cancer Cell; 2016 Feb; 29(2):201-13. PubMed ID: 26859459
[TBL] [Abstract][Full Text] [Related]
13. Tumor-derived fibulin-3 activates pro-invasive NF-κB signaling in glioblastoma cells and their microenvironment.
Nandhu MS; Kwiatkowska A; Bhaskaran V; Hayes J; Hu B; Viapiano MS
Oncogene; 2017 Aug; 36(34):4875-4886. PubMed ID: 28414309
[TBL] [Abstract][Full Text] [Related]
14. Evidence for the Involvement of the Master Transcription Factor NF-κB in Cancer Initiation and Progression.
Puar YR; Shanmugam MK; Fan L; Arfuso F; Sethi G; Tergaonkar V
Biomedicines; 2018 Jul; 6(3):. PubMed ID: 30060453
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of NF-κB results in anti-glioma activity and reduces temozolomide-induced chemoresistance by down-regulating MGMT gene expression.
Yu Z; Chen Y; Wang S; Li P; Zhou G; Yuan Y
Cancer Lett; 2018 Aug; 428():77-89. PubMed ID: 29705182
[TBL] [Abstract][Full Text] [Related]
16. Aberrant NF-kappaB activity is critical in focal necrosis formation of human glioblastoma by regulation of the expression of tissue factor.
Xie TX; Aldape KD; Gong W; Kanzawa T; Suki D; Kondo S; Lang F; Ali-Osman F; Sawaya R; Huang S
Int J Oncol; 2008 Jul; 33(1):5-15. PubMed ID: 18575745
[TBL] [Abstract][Full Text] [Related]
17. Notch1 promotes glioma cell migration and invasion by stimulating β-catenin and NF-κB signaling via AKT activation.
Zhang X; Chen T; Zhang J; Mao Q; Li S; Xiong W; Qiu Y; Xie Q; Ge J
Cancer Sci; 2012 Feb; 103(2):181-90. PubMed ID: 22093097
[TBL] [Abstract][Full Text] [Related]
18. IKK/NF-κB signaling contributes to glioblastoma stem cell maintenance.
Rinkenbaugh AL; Cogswell PC; Calamini B; Dunn DE; Persson AI; Weiss WA; Lo DC; Baldwin AS
Oncotarget; 2016 Oct; 7(43):69173-69187. PubMed ID: 27732951
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomas.
Bredel M; Bredel C; Juric D; Duran GE; Yu RX; Harsh GR; Vogel H; Recht LD; Scheck AC; Sikic BI
J Clin Oncol; 2006 Jan; 24(2):274-87. PubMed ID: 16365179
[TBL] [Abstract][Full Text] [Related]
20. Neural stem cells, inflammation and NF-kappaB: basic principle of maintenance and repair or origin of brain tumours?
Widera D; Kaus A; Kaltschmidt C; Kaltschmidt B
J Cell Mol Med; 2008 Apr; 12(2):459-70. PubMed ID: 18182066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
